Acquired Molecules. During the Term, if Rain or its Affiliates, as a result of a merger or other transaction, acquires or is acquired by a Third Party that is developing and/or distributing, marketing or selling, either on its own or through such Third Party’s affiliate or licensee, a product that contains Competing Compound, the surviving entity in such transaction shall discontinue development or commercialization of, or divest such Competing Compound within [***] after such transaction is completed (and any activities during such [***] period will not be a breach of this Agreement). Provided however, in the case Rain is acquired by a Third Party, such Third Party shall terminate this Agreement in its entirety on written notice to Daiichi Sankyo within thirty (30) days of such transaction if it decides not to discontinue development or commercialization of, or divest Competing Compound, in which case the effects of termination set forth in Section 10.5.1 will apply.
Acquired Molecules. If during the Term, as a result of a merger or other transaction, AnHeart acquires, or is acquired by a Third Party that is developing and/or distributing, marketing or selling, either on its own or through an Affiliate or licensee, a product that contains Competing Molecules, the surviving entity shall discontinue development of, or license out its rights with respect to such Competing Molecules within [**Redacted**] calendar days after the acquisition transaction is completed.
Acquired Molecules. If during the Term, as a result of a merger or other transaction, either Party acquires, or is acquired by a Third Party that is developing and/or distributing, marketing, or selling, either on its own or through an Affiliate or licensee, a product that contains Competing Molecules, the surviving entity [**Redacted**] such Competing Molecules within [**Redacted**] calendar days after the acquisition transaction is completed.
